Globalization has led to the proliferation of product liability laws and standards worldwide with an increase in cooperation and information sharing among countries in governmental action and investigations against pharmaceutical companies. The spread of collective redressal mechanisms and the growth of third-party funding of litigation costs has caused an increase in the regulatory interplay among nations.
Please refer to the below document to read the full article by Sanjay Kumar published in Express Pharma Magazine.
